Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Management of oxidative stress and other pathologies in Alzheimer’s disease
Miriama Šimunková, Saleh Alwasel, Ibrahim M. Alhazza, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 9, pp. 2491-2513
Open Access | Times Cited: 227
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Luke Cassidy, Francesca Fernandez, Joel B. Johnson, et al.
Complementary Therapies in Medicine (2019) Vol. 49, pp. 102294-102294
Closed Access | Times Cited: 222
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Gabriela Dumitrița Stanciu, Andrei Luca, Răzvan Nicolae Rusu, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 40-40
Open Access | Times Cited: 218
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi‐Rad, Chintha Lankatillake, Daniel A. Dias, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 204
The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases
Pamela Maher
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3056-3056
Open Access | Times Cited: 193
Antioxidant and Anti-Inflammatory Effects of Citrus Flavonoid Hesperetin: Special Focus on Neurological Disorders
Amjad Khan, Muhammad Ikram, Jong Ryeal Hahm, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 609-609
Open Access | Times Cited: 180
Recent Research on Flavonoids and their Biomedical Applications
Kangmei Wen, Xiaochuan Fang, Junli Yang, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 5, pp. 1042-1066
Closed Access | Times Cited: 179
Neuroprotective Natural Products for Alzheimer’s Disease
Xin Chen, Joshua Adam Drew, Wren Berney, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 149
Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
María Elena Gómez-Gómez, Sara C. Zapico
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2842-2842
Open Access | Times Cited: 144
The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
Antonella Calderaro, Giuseppe Tancredi Patanè, Ester Tellone, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14835-14835
Open Access | Times Cited: 77
Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases
Mootaz M. Salman, Zaid Al-Obaidi, Philip Kitchen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4688-4688
Open Access | Times Cited: 97
Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
Antonella Amato, Simona Terzo, Flavia Mulè
Antioxidants (2019) Vol. 8, Iss. 12, pp. 608-608
Open Access | Times Cited: 91
Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems
Rubiya Khursheed, Sachin Kumar Singh, Sheetu Wadhwa, et al.
Drug Discovery Today (2019) Vol. 25, Iss. 1, pp. 209-222
Closed Access | Times Cited: 89
Flavonoids and Mitochondria: Activation of Cytoprotective Pathways?
Anna Kicińska, Wiesl̵awa Jarmuszkiewicz
Molecules (2020) Vol. 25, Iss. 13, pp. 3060-3060
Open Access | Times Cited: 89
Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis
V. Prakash Reddy, Puspa Aryal, Sara Robinson, et al.
Microorganisms (2020) Vol. 8, Iss. 2, pp. 199-199
Open Access | Times Cited: 86
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
Shweta Devi, Vijay Kumar, Sandeep Kumar Singh, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 99-99
Open Access | Times Cited: 86
Exploring the efficacy of natural products in alleviating Alzheimer’s disease
Amit Singh, Prajakta Deshpande, Neha Gogia
Neural Regeneration Research (2019) Vol. 14, Iss. 8, pp. 1321-1321
Open Access | Times Cited: 85
Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids
Tae Yeon Kim, Eunju Leem, Jae Man Lee, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 583-583
Open Access | Times Cited: 84
Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation
Shelby L. Johnson, Riley D. Kirk, Nicholas A. DaSilva, et al.
Metabolites (2019) Vol. 9, Iss. 4, pp. 78-78
Open Access | Times Cited: 78
Map kinase signaling as therapeutic target for neurodegeneration
Touqeer Ahmed, Abida Zulfiqar, Sandro Argüelles, et al.
Pharmacological Research (2020) Vol. 160, pp. 105090-105090
Closed Access | Times Cited: 76
Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications
Efthalia Angelopoulou, Efstratios‐Stylianos Pyrgelis, Christina Piperi
Neurochemistry International (2019) Vol. 132, pp. 104612-104612
Closed Access | Times Cited: 75
Flavonoids Regulate Inflammation and Oxidative Stress in Cancer
Guangxing Li, Kaiyue Ding, Yanling Qiao, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5628-5628
Open Access | Times Cited: 75
Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer’s Disease
Tarun Minocha, Hareram Birla, Ahmad A. Obaid, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 63
Neuroprotective Effects and Therapeutic Potential of the Citrus Flavonoid Hesperetin in Neurodegenerative Diseases
Jasmine A. Evans, Patricia Mendonca, Karam F. A. Soliman
Nutrients (2022) Vol. 14, Iss. 11, pp. 2228-2228
Open Access | Times Cited: 60
Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease
Xinyuan Zhang, Samantha Molsberry, Tian‐Shin Yeh, et al.
Neurology (2022) Vol. 98, Iss. 10
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top